Local Anaesthesia Drugs Market Size, Share, Forecast 2033

Description
Table of Contents

The global local anaesthesia drugs market is expected to grow at a CAGR of around 3.8% during 2024-2033. This report on global local anaesthesia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global local anaesthesia drugs market by segmenting the market based on drug type, mode of administration, distribution channel and region. Also, detailed profiles of companies operating in the local anaesthesia drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

The global growth of the local anesthesia market is strongly driven by the increasing demand for medical procedures. The expanding population, coupled with the rising prevalence of chronic diseases such as cancer and diabetes and high hospitalization rates due to these diseases, drives the need for various surgical interventions and diagnostic procedures. Further, the local anesthesia drug market is being driven by significant advancements in drug formulations and delivery systems. These advancements aim to improve the efficacy, safety, and patient experience of local anesthesia administration. One key driver is the development of advanced drug formulations that offer extended-release properties such as articaine, levobupivacaine, and ropivacaine. These formulations provide prolonged pain relief, reducing the need for frequent administration and enhancing patient comfort

Market Restraints

The local anesthesia drug market is highly competitive in nature owing to a growing number of players entering the new market, both established medical companies and new entrants. All the players are primarily contending on parameters such as quality, cost-effectiveness, innovation, and speed to market. Further, safety concerns and litigation pose significant challenges and restrict the growth of the local anesthesia market. These concerns arise due to the potential risks and adverse effects associated with the use of anesthesia drugs. Instances of adverse events, such as allergic reactions, systemic toxicity, nerve damage, or prolonged anesthesia, can erode the confidence of healthcare professionals and patients in the safety and efficacy of these drugs. Moreover, any safety issues or adverse events can result in regulatory actions, product recalls, litigation, and damage to the reputation of drug manufacturers.

Market Opportunities

Technological advancements in surgical techniques have played a pivotal role in driving the growth and demand for local anaesthesia drugs. These advancements have revolutionized the field of surgery, enabling more precise, minimally invasive procedures with improved patient outcomes. One significant driver is the development and widespread adoption of minimally invasive surgical techniques. Further, the rising healthcare expenditure worldwide is another key driver for the local anesthesia market. Increased healthcare spending is driven by factors such as population growth, advancements in medical technologies, and improved access to healthcare services. As healthcare expenditure increases, there is a corresponding rise in the utilization of medical procedures and surgeries, which require effective pain management options.

Industry Development

In Jan 2022, Théa, a prominent independent pharmaceutical company in Europe renowned for its focus on eye-care products’ research, development, and commercialization, has signed a deal to acquire seven branded ophthalmic products from Akorn Operating Company LLC.
In Mar, 2021, Pacira BioSciences Inc. submitted a supplemental new drug application (sNDA) seeking expanded approval for the use of Exparel (Bupivacaine Liposome Injectable Suspension) in pediatric patients. This application was subsequently approved by the U.S. Food and Drug Administration (FDA).

Gypsum Board Market Report Highlights:

The lidocaine segment dominated the global local anaesthesia market by drug type with 25.8% in 2023. Lidocaine is a commonly used local anesthetic that provides temporary numbing or pain relief in various medical and dental procedures.
Based on mode of administration, injectable dominated segment held the largest market share of 61.4% in 2023 and is anticipated to dominate the market over the forecast period.
Based on distribution channel, hospital pharmacy dominated segment & held the largest market share of 67.4% in 2023 and is anticipated to dominate the market over the forecast period. The primary locations for both major and small surgical procedures are hospitals. Drugs for local anesthesia are essential to hospital pharmacy operations since they are frequently used during procedures to numb particular body parts.
North America generated the highest revenue in 2023 with a 40.2% revenue share. North America has a high prevalence of surgical procedures, including both major and minor surgeries. Local anaesthesia drugs are commonly used in these procedures to provide pain relief and ensure patient comfort.

Historical & Forecast Period

Base Year: 2023

Historical Period: 2019-2023

Forecast Period: 2024-2033

Report’s Unit: US$

Global Local Anaesthesia Drugs Market, Regional Analysis

Global Local Anaesthesia Drugs Market Segmentation

Market by Drug Type

Lidocaine
Bupivacaine
Prilocaine
Ropivacaine
Benzocaine
Chloroprocaine
Others

Market by Mode of Administration

Injectable
Surface Anaesthetic

Market by Distribution Channel

Hospital Pharmacy
Pharmacy Stores
Others

Market by Region

Europe

Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Sweden
Poland
Rest of Europe

North America

United States
Canada

Asia Pacific

China
Japan
India
South Korea
Australia
ASEAN
Rest of Asia Pacific

Latin America

Mexico
Brazil
Argentina
Chile
Rest of Latin America

Middle East & Africa

Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

List of Mentioned Companies

Report Coverage

Report Feature	Details
Base Year	2023
Historical Period	2019-2022
Forecast Period	2024-2033
Units	US$ Million
Segments Covered	Drug Type, Mode of Administration, Distribution Channel, Region
Region Covered	Europe, North America, Asia Pacific, Latin America, Middle East and Africa
Companies Covered	Aspen Pharmacare Holdings Limited, B. Braun Melsulgen AG., Baxter International Inc., Endo International Plc, Fresenius SE & Co. KGaA, Glenmark Pharmaceuticals Ltd, Hikma Pharmaceuticals Plc, Pacira BioSciences Inc, Pfizer Inc, Pierrel S.p.A., Septodont, Teva Pharmaceutical Industries Limited
Purchase Options	Single User License: US$ 2,999 Five User License: US$ 3,499 Corporate License: US$ 4,499

Research Methodology

During the course of the research study, we conducted extensive primary and secondary research. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper the growth in the market.

Comprehensive primary and secondary methods helped us to identify the trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.

Breakdown of Primary Research Participant's Profiles Post-secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide an accurate market scenario in our report.

Key Questions Answered in the Report

What will be the global local anaesthesia drugs market size and the growth rate in the coming year?
What are the main key factors driving the market?
What are the key market trends impacting the growth of the market?
What are the market opportunities and threats in the market?
What industrial trends, drivers, and challenges are manipulating its growth?
Which are trending factors influencing the market shares of the top regions across the globe?
Who are the key market players in the industry?
What is the impact of Covid19 on the current industry?

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
2.1. Global Market in 2023
2.2. Impact of COVID-19
2.3. Growth Opportunities and Challenges
2.4. Key Industry Trends
3. Global Market Dynamics
3.1. Introduction
3.2. Market DROs
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Industry Trends
3.4. SWOT Analysis
3.5. Market Value Chain Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Key Price Indicators
3.9. Ansoff Matrix
3.10. Government Laws and Industry Regulations
4. Global Local Anaesthesia Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size (US$ Million, 2019-2023)
4.3. Market Forecast (US$ Million, 2024-2033)
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Local Anaesthesia Drugs Market by Drug Type (US$ Million, 2019-2033)
5.1. Introduction
5.2. Lidocaine
5.3. Bupivacaine
5.4. Prilocaine
5.5. Ropivacaine
5.6. Benzocaine
5.7. Chloroprocaine
5.8. Others
5.9. Key Segment Investment Opportunity
6. Global Local Anaesthesia Drugs Market by Mode of Administration (US$ Million, 2019-2033)
6.1. Introductions
6.2. Injectable
6.3. Surface Anaesthetic
6.4. Key Segment Investment Opportunity
7. Global Local Anaesthesia Drugs Market by Distribution Channel (US$ Million, 2019-2033)
7.1. Introductions
7.2. Hospital Pharmacy
7.3. Pharmacy Stores
7.4. Others
7.5. Key Segment Investment Opportunity
8. Global Local Anaesthesia Drugs Market by Region (US$ Million, 2019-2033)
8.1. Introduction
8.2. Europe
8.3. North America
8.4. Asia Pacific
8.5. Latin America
8.6. Middle East & Africa
8.7. Key Segment Investment Opportunity
9. Europe Local Anaesthesia Drugs Market (US$ Million, 2019-2033)
9.1. Introduction
9.2. Key Drivers and Takeaways
9.3. Europe Market Breakup by Drug Type
9.4. Europe Market Breakup by Mode of Administration
9.5. Europe Market Breakup by Distribution Channel
9.6. Europe Market Breakup by Country
9.6.1. Germany
9.6.2. United Kingdom
9.6.3. France
9.6.4. Italy
9.6.5. Spain
9.6.6. Russia
9.6.7. Netherlands
9.6.8. Sweden
9.6.9. Poland
9.6.10. Rest of Europe
10. North America Local Anaesthesia Drugs Market (US$ Million, 2019-2033)
10.1. Introduction
10.2. Key Drivers and Takeaways
10.3. North America Market Breakup by Drug Type
10.4. North America Market Breakup by Mode of Administration
10.5. North America Market Breakup by Distribution Channel
10.6. North America Market Breakup by Country
10.6.1. United States
10.6.2. Canada
11. Asia Pacific Local Anaesthesia Drugs Market (US$ Million, 2019-2033)
11.1. Introduction
11.2. Key Drivers and Takeaways
11.3. Asia Pacific Market Breakup by Drug Type
11.4. Asia Pacific Market Breakup by Mode of Administration
11.5. Asia Pacific Market Breakup by Distribution Channel
11.6. Asia Pacific Market Breakup by Country
11.6.1. China
11.6.2. Japan
11.6.3. India
11.6.4. South Korea
11.6.5. Australia
11.6.6. ASEAN
11.6.7. Rest of Asia Pacific
12. Latin America Local Anaesthesia Drugs Market (US$ Million, 2019-2033)
12.1. Introduction
12.2. Key Drivers and Takeaways
12.3. Latin America Market Breakup by Drug Type
12.4. Latin America Market Breakup by Mode of Administration
12.5. Latin America Market Breakup by Distribution Channel
12.6. Latin America Market Breakup by Country
12.6.1. Mexico
12.6.2. Brazil
12.6.3. Argentina
12.6.4. Chile
12.6.5. Rest of Latin America
13. Middle East and Africa Local Anaesthesia Drugs Market (US$ Million, 2019-2033)
13.1. Introduction
13.2. Key Drivers and Takeaways
13.3. Middle East and Africa Market Breakup by Drug Type
13.4. Middle East and Africa Market Breakup by Mode of Administration
13.5. Middle East and Africa Market Breakup by Distribution Channel
13.6. Middle East and Africa Market Breakup by Country
13.6.1. Saudi Arabia
13.6.2. Turkey
13.6.3. Iran
13.6.4. United Arab Emirates
13.6.5. Rest of Middle East & Africa
14. Competitive Landscape
14.1. Competitive Dashboard
14.2. Key Industry Strategies Analysis
14.3. Recent Developments
14.4. Market Scenario
15. Company Profiles
15.1. Aspen Pharmacare Holdings Limited
15.2. B. Braun Melsulgen AG.
15.3. Baxter International Inc.
15.4. Endo International Plc
15.5. Fresenius SE & Co. KGaA
15.6. Glenmark Pharmaceuticals Ltd
15.7. Hikma Pharmaceuticals Plc
15.8. Pacira BioSciences Inc
15.9. Pfizer Inc
15.10. Pierrel S.p.A.
15.11. Septodont
15.12. Teva Pharmaceutical Industries Limited

Description